Quick links

FREEDOM FROM FIBROIDS

The non-invasive, outpatient uterine fibroids treatment is an alternative to hysterectomy, myomectomy and UAE. ExAblate treats uterine fibroids (myomas) using MR-guided focused ultrasound. More than 9500 women have already undergone this incisonless procedure.

Why choose ExAblate for treating your uterine fibroids?

- It's non-invasive - so there's no cutting or general anesthesia
- It's an outpatient procedure - so in most cases there's no hospital stay
- It's not experimental - so it's safe for use and reduces the risk of side effects
- There's a short recovery time - you'll return to livelihood quickly

What are uterine fibroids?
Uterine fibroids (non-cancerous tumors) are quite common - affecting between 20-50% of women of childbearing age. While many women do not experience any problems, symptoms can be severe enough to require treatment. Read more about fibroids.

What are the key symptoms of uterine fibroids?

Heavy and prolonged periods
Bleeding between periods
Lower back or leg pain
Pain during sexual intercourse
Need for frequent urination caused by bladder pressure
Feeling of fullness in the lower abdomen

Find a treatment center

Download a patient information brochure

Flash news

December 1, 2012 Recruiting patients for a study comparing the use of ExAblate to Uterine Artery Embolization at Mayo Clinic

Mayo Clinic and Duke University are conducting the first study to compare uterine artery embolization (UAE) and MR-guided focused ultrasound (MRgFUS) for the treatment of uterine fibroids.

The study‚ called Fibroid Interventions: Reducing Symptoms Today and Tomorrow (FIRSTT)‚ will randomly assign women to be treated with either UAE or MRgFUS. The study will follow patients for three years to assess how effective the treatments are in symptom relief‚ absence of side effects‚ impact on quality of life‚ need for additional treatment‚ and even the costs associated with each approach.

The primary goal of this study is to compare the safety and effectiveness of two standard fibroid treatments: MRI guided ultrasound surgery (MRgFUS) and uterine artery embolization (UAE). Both treatments are approved by the Food and Drug Administration (FDA) for women who do not plan to become pregnant.A second goal of this study is to better understand which symptoms bother women with fibroids the most. Understanding and addressing the symptoms of clinically-significant uterine fibroids is important in order to optimize treatment outcomes and control health care costs.Women who are eligible to participate in the study‚ are randomized to one of two treatment arms (UAE or MRgFUS). Women in both arms will receive treatment but will not be able to choose which treatment she will receive.A comprehensive assessment of symptoms-including experienced pain- will take place at baseline‚ 6 weeks‚ and at 6‚ 12‚ 24‚ and 36 months following treatment with UAE and MRgFUS.

The study is now enrolling 220 women who can be treated at Mayo Clinic in Rochester‚ Minnesota or Duke University in Durham‚ North Carolina. Call Lisa G. Peterson‚ RN 507-266-4813

To find out more about the study and whether you are eligible to participate‚ please click here.

Additional information can also be found here: http://clinicaltrials.gov/ct2/show/NCT00995878?term=Magnetic+Resonance-guided+Focused+Ultrasound&rank=7

Uterine Fibroids Treatment that is Not Invasive

Send to a friend

Videos

This text will be replaced

Listen to doctors and patients talk about their experience with non-invasive treatment for uterine fibroids

Dr. Matzko (Klinikum Dachau Germany)‚ talks about the ExAblate treatment for uterine fibroids .